Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasopressin excess and hyponatremia.

Phuong-Chi T Pham1, Phuong-Mai T Pham, Phuong-Thu T Pham

  • 1Nephrology Division, Olive View-UCLA Medical Center, Sylmar, CA 91342, USA. pctp@ucla.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety Net kidney after liver transplantation: unexpected renal recovery in a liver transplant recipient after more than 10 months on maintenance hemodialysis - a case report.

Frontiers in nephrology·2026
Same author

Editorial: Management of patients with a failed kidney transplant: perspectives from transplant nephrologist, infectious disease, immunogenetics, oncology and transplant surgeons.

Frontiers in nephrology·2024
Same author

Comments on: The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.

Transplantation·2024
Same author

Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients.

Frontiers in nephrology·2023
Same author

DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients.

Transplantation direct·2020
Same author

Kidney Court: Not Just Another Journal Club.

Journal of graduate medical education·2017

Hyponatremia, often overlooked, involves excess arginine vasopressin (AVP). AVP-receptor antagonists offer a novel treatment by promoting water excretion to correct low sodium levels.

Area of Science:

  • Endocrinology
  • Nephrology
  • Internal Medicine

Background:

  • Hyponatremia is a prevalent electrolyte disorder often underdiagnosed and undertreated.
  • Arginine vasopressin (AVP) plays a key role in hyponatremia pathophysiology due to excess release.
  • Current treatments may not fully address AVP-induced water retention.

Purpose of the Study:

  • To review recent clinical trial data on AVP-receptor antagonists for hyponatremia.
  • To evaluate the efficacy of these agents in correcting serum sodium levels.

Main Methods:

  • Review of clinical trials involving AVP-receptor antagonists (lixivaptan, tolvaptan, conivaptan).
  • Focus on studies addressing hyponatremia associated with AVP excess.

Main Results:

Related Experiment Videos

  • AVP-receptor antagonists demonstrated aquaresis, facilitating electrolyte-sparing free water excretion.
  • These agents effectively correct serum sodium concentration in patients with hyponatremia.

Conclusions:

  • AVP-receptor antagonists represent a promising therapeutic strategy for hyponatremia.
  • Targeting the AVP pathway offers a direct approach to managing water retention in hyponatremia.